Efficacy and safety of ipragliflozin as an add-on to pioglitazone in Japanese patients with inadequately controlled type 2 diabetes : a randomized, double-blind, placebo-controlled study : the SPOTLIGHT study

この論文をさがす

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ